Michael Horwitz, DO

Cardiovascular Disease (cardiology) in Willingboro, NJ

218 Sunset Rd, Fl 5, Willingboro, NJ 08046 · Virtua Medical Group, PA
NPI 1386842987 Accepts Medicare assignment 21 years since graduation Public record — not managed by the clinician

About Dr. Michael Horwitz

Dr. Michael Horwitz is a physician specializing in cardiovascular disease (cardiology) practicing in Willingboro, NJ, a graduate of Rutgers New Jersey Medical School (2005). Records list 7 practice addresses. Affiliated with Virtua Mount Holly Hospital, Virtua Our Lady of Lourdes Hospital, Virtua Willingboro Hospital and 1 more. Treated 884 Medicare patients in 2024.

SpecialtyCardiovascular Disease (cardiology)Other cardiovascular disease (cardiology) doctors in Willingboro
Also practicesInternal Medicine
CredentialsDO
EducationRutgers New Jersey Medical School, 2005CMS Doctors and Clinicians
GenderMale
NPI number1386842987National Provider Identifier (CMS NPPES), issued July 2007
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Where Dr. Michael Horwitz practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Michael Horwitz's specialties and state licenses

Specialty (NPPES)License
Nuclear Cardiology PrimaryNJ 25MB08426600
Cardiovascular DiseaseNJ 25MB08426600

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Michael Horwitz

  • Virtua Mount Holly HospitalHospital · Mount Holly, NJ
  • Virtua Our Lady of Lourdes HospitalHospital · Camden, NJ
  • Virtua Willingboro HospitalHospital · Willingboro, NJ
  • West Jersey HospitalHospital · Voorhees, NJ

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Michael Horwitz's Medicare patients and services (2024)

884Medicare patients
2,007services billed
74average patient age
54%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more667$140.56
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only447$8.79
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report337$15.81
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function160$74.01
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes88$140.97
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes57$86.28
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more54$181.59
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician21$22.74

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis49%
  • Diabetes48%
  • Ischemic heart disease43%
  • Chronic kidney disease38%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Michael Horwitz's Medicare quality score (MIPS 2024)

81.2/100final MIPS score
62.3quality
100promoting interoperability
40improvement activities
74.9cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Michael Horwitz (2025)

$848.38 in 40 general payments reported in 2025.

TypePaymentsAmount
Food and beverage40$848.38

Paying companies: NOVARTIS PHARMACEUTICALS CORPORATION ($198.44), ABIOMED ($128.20), Merck Sharp & Dohme LLC ($88.18), scPharmaceuticals Inc. ($55.08), Boehringer Ingelheim Pharmaceuticals, Inc. ($47.69), Alnylam Pharmaceuticals Inc. ($37.27).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Michael Horwitz

What kind of clinician is Dr. Michael Horwitz?

Dr. Michael Horwitz is listed as a physician specializing in cardiovascular disease (cardiology), also practicing internal medicine.

Where does Dr. Michael Horwitz practice?

Virtua Medical Group, PA at 218 Sunset Rd, Fl 5, Willingboro, NJ 08046, and 6 other addresses in the records.

What is the office phone number for Dr. Michael Horwitz?

The listed office number is (609) 444-0359. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Michael Horwitz?

The National Provider Identifier is 1386842987.

Does Dr. Michael Horwitz accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Michael Horwitz affiliated with?

Virtua Mount Holly Hospital, Virtua Our Lady of Lourdes Hospital, Virtua Willingboro Hospital, West Jersey Hospital.

Where did Dr. Michael Horwitz go to medical school?

Rutgers New Jersey Medical School, graduating in 2005.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2025-02-28
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare